Evidence map›Paper›PMID 38101850›Full record

Trial reportBMJ open2023

Impact of an Acceptance and Commitment Therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial.

Ingrid Wijk, Susanne Amsberg, Unn-Britt Johansson, Fredrik Livheim, Eva Toft, Therese Anderbro

Registry-linked trialOpen access · goldAbstract readRandomized Controlled Trial
In one paragraph

Trial report in BMJ open, 2023. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT02914496 ("Diabetes in Balance" - a Randomized Controlled Trial to Evaluate the Effects on Glucose Control, Self-care and Psychosocial Factors?), which is not on this map. Cited by 8 papers.

0numbers the graph read from it
0cells of the map it votes in
8citing papers in PubMed
2.4field-weighted citation impact, top 9% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT02914496 naactive not recruitingnot on this map

"Diabetes in Balance" - a Randomized Controlled Trial to Evaluate the Effects on Glucose Control, Self-care and Psychosocial Factors?

TypeinterventionalSponsorKarolinska InstitutetRan2016 to 2025Enrolled81ConditionsType 1 DiabetesArmsAcceptance and Commitment Therapy (ACT)
3 · Its place in the literature

Who cites it

8 citing papers in PubMed, 12 citations in OpenAlex.

  1. Trial
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 4 institutions in 1 country.

Ingrid WijkDepartment of Health Promoting Science, Sophiahemmet University, Stockholm, Sweden ingrid.wijk@shh.se.ORCID 0000-0001-8967-1342
Susanne AmsbergDepartment of Health Care Sciences, Marie Cederschiöld University, Stockholm, Sweden.
Unn-Britt JohanssonDepartment of Health Promoting Science, Sophiahemmet University, Stockholm, Sweden.
Fredrik LivheimDepartment of Clinical Neuroscience, Karolinska Institutet, Stockholm, Sweden.
Eva ToftDepartment of Medicine, Huddinge, Karolinska Institutet, Stockholm, Sweden.
Therese AnderbroDepartment of Clinical Sciences, Danderyd Hospital, Karolinska Institutet, Stockholm, Sweden.
Karolinska Institutet · SESophiahemmet University College · SEMarie Cederschiöld University · SEStockholm University · SE

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveTo evaluate the impact of an Acceptance and Commitment Therapy (ACT) programme, tailored for people living with type 1 diabetes, on glycated haemoglobin (HbA1c), self-management and psychosocial factors among individuals with HbA1c>60 mmol/mol compared with treatment as usual (TAU).

settingAn endocrinologic clinic in Sweden.

participantsIn this randomised controlled trial, 81 individuals with type 1 diabetes, aged 18-70 years with HbA1c>60 mmol/mol, were randomly assigned to either an ACT group intervention or TAU. Exclusion criteria were: unable to speak Swedish, untreated or severe psychiatric disease, cortisone treatment, untreated thyroid disease and newly started insulin pump therapy. At the 2-year follow-up, HbA1c was measured in 26 individuals.

interventionThe ACT programme comprised seven 2-hour sessions held over 14 weeks and focused on acceptance of stressful thoughts and emotions, and to promote value-based committed action. OUTCOMES: The primary outcome was HbA1c, and the secondary outcomes were measures of depression, anxiety, general stress, fear of hypoglycaemia, diabetes distress, self-care activities, psychological flexibility (general and related to diabetes) and quality of life. The primary endpoint was HbA1c 2 years after the intervention programme. Linear mixed models were used to test for an interaction effect between measurement time and group.

resultsLikelihood ratio test of nested models demonstrated no statistically significant interaction effect (χ

conclusionsNo statistically significant difference was found between the groups regarding the primary outcome measure, HbA1c. However, the ACT programme showed a persistent beneficial impact on psychological flexibility in the intervention group. The dropout rate was higher than expected, which may indicate a challenge in this type of study. TRIAL REGISTRATION NUMBER: NCT02914496.

Indexed as

Acceptance and Commitment TherapyDiabetes Mellitus, Type 1Self-ManagementAdolescentAdultAgedGlycated HemoglobinHumansMiddle AgedQuality of LifeYoung AdultGlycated HemoglobinDepression & mood disordersDIABETES & ENDOCRINOLOGYPREVENTIVE MEDICINE

Identifiers

PMID38101850
PMCPMC10729111
OpenAlexW4389795324

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.